Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Wachtell

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Does lowering cholesterol have an impact on the progression of aortic stenosis?Anders M Greve, Kristian Wachtell
Nature Clinical Practice. Nephrology|October 15, 2008
Is it time to change the definition of normal urinary albumin excretion?Kristian Wachtell, Michael H Olsen
Journal of Atrial Fibrillation|May 13, 2017
The Relationship Between Physical Activity and Risk of Atrial Fibrillation-A Systematic Review and Meta-AnalysisJens Rokkedal Nielsen, Kristian Wachtell, Jawdat Abdulla
Current Cardiology Reports|September 8, 2006
Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillationKristian Wachtell, Richard B Devereux, Paulette A Lyle
Ugeskrift for Laeger|August 13, 2009
[Hypertension and the heart]Kristian Wachtell, Niels Holmark Andersen, Tage Lysbo Svendsen
Current Hypertension Reports|August 10, 2007
The effect of angiotensin receptor blockers for preventing atrial fibrillationKristian Wachtell, Richard B Devereux, And Paulette A Lyle
European Journal of Heart Failure|February 28, 2004
N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosisPer Hildebrandt, Mikael Boesen, Michael Olsen, et al.
Cardiology|August 30, 2007
Pre-discharge exercise test for evaluation of patients with complete or incomplete revascularization following primary percutaneous coronary intervention: a DANAMI-2 sub-studyNana Valeur, Peter Clemmensen, Peer Grande, et al.
Blood Pressure|May 1, 2010
Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy)Nora Tuseth, Dana Cramariuc, Ashild E Rieck, et al.
European Heart Journal|January 18, 2007
Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplastyDan Eik Høfsten, Kristian Wachtell, Birgit Lund, et al.
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Does lowering cholesterol have an impact on the progression of aortic stenosis?Anders M Greve, Kristian Wachtell
Nature Clinical Practice. Nephrology|October 15, 2008
Is it time to change the definition of normal urinary albumin excretion?Kristian Wachtell, Michael H Olsen
Journal of Atrial Fibrillation|May 13, 2017
The Relationship Between Physical Activity and Risk of Atrial Fibrillation-A Systematic Review and Meta-AnalysisJens Rokkedal Nielsen, Kristian Wachtell, Jawdat Abdulla
Current Cardiology Reports|September 8, 2006
Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillationKristian Wachtell, Richard B Devereux, Paulette A Lyle
Ugeskrift for Laeger|August 13, 2009
[Hypertension and the heart]Kristian Wachtell, Niels Holmark Andersen, Tage Lysbo Svendsen
Current Hypertension Reports|August 10, 2007
The effect of angiotensin receptor blockers for preventing atrial fibrillationKristian Wachtell, Richard B Devereux, And Paulette A Lyle
European Journal of Heart Failure|February 28, 2004
N-terminal pro brain natriuretic peptide in arterial hypertension--a marker for left ventricular dimensions and prognosisPer Hildebrandt, Mikael Boesen, Michael Olsen, et al.
Cardiology|August 30, 2007
Pre-discharge exercise test for evaluation of patients with complete or incomplete revascularization following primary percutaneous coronary intervention: a DANAMI-2 sub-studyNana Valeur, Peter Clemmensen, Peer Grande, et al.
Blood Pressure|May 1, 2010
Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy)Nora Tuseth, Dana Cramariuc, Ashild E Rieck, et al.
European Heart Journal|January 18, 2007
Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplastyDan Eik Høfsten, Kristian Wachtell, Birgit Lund, et al.
Pageof 21